David A. Siegel Equillium, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
12.3MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$4.89 Million0.35% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$4.89 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$1.45 Million0.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$618,505100.0% of portfolio
-
Abrdn PLC380KShares$417,4780.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $37.8M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...